Failure patterns after adjuvant chemoradiotherapy following endoscopic resection for superficial esophageal squamous cell carcinoma. (20th June 2019)

• Record Type: Journal Article
• Authors: Ikawa, Toshiki; Ishihara, Ryu; Konishi, Koji; Morimoto, Masahiro; Hirata, Takero; Kanayama, Naoyuki; Yamamoto, Sachiko; Matsuura, Noriko; Wada, Kentaro; Hayashi, Kenji; Ogawa, Kazuhiko; Teshima, Teruki
• Is Part Of: Cancer medicine. Volume 8:Number 10(2019:Aug.)
• Page Start: 4547
• Page End: 4554
• Publication Date: 2019-06-20
• Subjects: chemoradiotherapy -- endoscopic resection -- esophageal neoplasms -- squamous cell carcinoma; 616.994005
• DOI: 10.1002/cam4.2365
• Languages: English
• ISSNs: 2045-7634

Abstract

Abstract: Background: This study evaluated the locations of lymph node recurrence and their association with irradiation fields used for radiotherapy after adjuvant chemoradiotherapy following endoscopic resection for superficial esophageal squamous cell carcinoma. Methods: Medical records of 96 consecutive patients with superficial esophageal squamous cell carcinoma who underwent adjuvant chemoradiotherapy following endoscopic resection were reviewed. Computed tomography was used to identify whether nodal recurrences were within the elective nodal irradiation field. The cumulative incidence of recurrence was calculated, accounting for death as a competing risk. Univariate and multivariate analyses identified factors predicting nodal recurrence. Results: The median follow‐up period was 61 months (range: 6‐137 months). Seven patients (7.3%) developed lymph node recurrence only; two patients (2.1%) developed nodal plus local recurrence. Six of the seven cases without local recurrence involved the elective nodal irradiation field, with five cases involving the recurrent nerve lymph nodes. The 5‐year cumulative incidence of lymph node recurrence was higher for T1b tumors with lymphovascular invasion than for T1a tumors with lymphovascular invasion (17.6% vs 6.2%, P = 0.086; HR: 3.74, 95% CI: 0.80‐17.52, P = 0.094) and T1b tumors without lymphovascular invasion (17.6% vs 3.3%, P = 0.031; HR: 6.78, 95% CI: 0.80‐57.63, P = 0.080). Conclusions: Lymph node recurrence frequently involved the elective nodal irradiation field, with recurrent nerve lymph nodes being common metastasis sites. The high incidence of nodal recurrence for T1b tumors with lymphovascular invasion highlights a need for new strategies for treating this subset of superficial esophageal squamous cell carcinomas. Abstract : This study evaluated the locations of lymph node recurrence and their association with irradiation fields used for radiotherapy after adjuvant chemoradiotherapy following endoscopic resection for superficial esophageal squamous cell carcinoma. There is a high incidence of nodal recurrence for T1b tumors with lymphovascular invasion. New strategies for treating this subset of superficial esophageal squamous cell carcinomas are required.